Literature DB >> 24917961

Fistulizing Crohn's disease: Diagnosis and management.

Krisztina Gecse1, Reena Khanna2, Jaap Stoker3, John T Jenkins4, Simon Gabe5, Dieter Hahnloser6, Geert D'Haens1.   

Abstract

Fistulizing Crohn's disease represents an evolving, yet unresolved, issue for multidisciplinary management. Perianal fistulas are the most frequent findings in fistulizing Crohn's disease. While enterocutaneous fistulas are rare, they are associated with considerable morbidity and mortality. Detailed evaluation of the fistula tract by advanced imaging techniques is required to determine the most suitable management options. The fundamentals of perianal fistula management are to evaluate the complexity of the fistula tract, and exclude proctitis and associated abscess. The main goals of the treatment are abscess drainage, which is mandatory, before initiating immunosuppressive medical therapy, resolution of fistula discharge, preservation of continence and, in the long term, avoidance of proctectomy with permanent stoma. The management of enterocutaneous fistulas comprises of sepsis control, skin care, nutritional optimization and, if needed, delayed surgery.

Entities:  

Keywords:  Crohn’s disease; anti-TNF therapy; enterocutaneous fistula; inflammatory bowel disease; perianal fistula

Year:  2013        PMID: 24917961      PMCID: PMC4040755          DOI: 10.1177/2050640613487194

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  60 in total

Review 1.  AGA technical review on perianal Crohn's disease.

Authors:  William J Sandborn; Victor W Fazio; Brian G Feagan; Stephen B Hanauer
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

2.  Combined approach with biologics and surgery for enterocutaneous fistulas in Crohn's disease.

Authors:  Walter Fries; Giuseppe La Malfa; Giuseppe Costantino; Alessandro Repici; Silvio Mazziotti; Giuseppe Navarra
Journal:  Inflamm Bowel Dis       Date:  2011-02       Impact factor: 5.325

3.  A classification of fistula-in-ano.

Authors:  A G Parks; P H Gordon; J D Hardcastle
Journal:  Br J Surg       Date:  1976-01       Impact factor: 6.939

Review 4.  Nutrition and management of enterocutaneous fistula.

Authors:  D A J Lloyd; S M Gabe; A C J Windsor
Journal:  Br J Surg       Date:  2006-09       Impact factor: 6.939

5.  Prospective comparison of endosonography, magnetic resonance imaging and surgical findings in anorectal fistula and abscess complicating Crohn's disease.

Authors:  P Orsoni; M Barthet; F Portier; M Panuel; A Desjeux; J C Grimaud
Journal:  Br J Surg       Date:  1999-03       Impact factor: 6.939

6.  Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease.

Authors:  Jean-Charles Grimaud; Nicolas Munoz-Bongrand; Laurent Siproudhis; Laurent Abramowitz; Agnès Sénéjoux; Véronique Vitton; Luc Gambiez; Bernard Flourié; Xavier Hébuterne; Edouard Louis; Benoit Coffin; Vincent De Parades; Guillaume Savoye; Jean-Claude Soulé; Yoram Bouhnik; Jean-Frédéric Colombel; Jean-François Contou; Yves François; Jean-Yves Mary; Marc Lémann
Journal:  Gastroenterology       Date:  2010-02-20       Impact factor: 22.682

7.  A multivariate model to determine prognostic factors in gastrointestinal fistulas.

Authors:  A C Campos; D F Andrade; G M Campos; J E Matias; J C Coelho
Journal:  J Am Coll Surg       Date:  1999-05       Impact factor: 6.113

8.  High-output external fistulae of the small bowel: management with continuous enteral nutrition.

Authors:  E Lévy; P Frileux; P H Cugnenc; J Honiger; J M Ollivier; R Parc
Journal:  Br J Surg       Date:  1989-07       Impact factor: 6.939

9.  Evaluation of surgery for perianal Crohn's fistulas.

Authors:  H J Scott; J M Northover
Journal:  Dis Colon Rectum       Date:  1996-09       Impact factor: 4.585

10.  Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group.

Authors:  E J Irvine
Journal:  J Clin Gastroenterol       Date:  1995-01       Impact factor: 3.062

View more
  10 in total

Review 1.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

Review 2.  Disease monitoring in inflammatory bowel disease.

Authors:  Shannon Chang; Lisa Malter; David Hudesman
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

3.  First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus.

Authors:  Maryam Alkhatry; Ahmad Al-Rifai; Vito Annese; Filippos Georgopoulos; Ahmad N Jazzar; Ahmed M Khassouan; Zaher Koutoubi; Rahul Nathwani; Mazen S Taha; Jimmy K Limdi
Journal:  World J Gastroenterol       Date:  2020-11-21       Impact factor: 5.742

4.  A Challenging Treatment Decision for a Rare Association: Case Report of Familial Turcot Syndrome With Fistulizing Crohn's Disease.

Authors:  Montserrat Corbera-Hincapie; Genie L Beasley
Journal:  Front Pediatr       Date:  2018-04-04       Impact factor: 3.418

Review 5.  Optimized timing of using infliximab in perianal fistulizing Crohn's disease.

Authors:  Xue-Liang Sun; Shi-Yi Chen; Shan-Shan Tao; Li-Chao Qiao; Hong-Jin Chen; Bo-Lin Yang
Journal:  World J Gastroenterol       Date:  2020-04-14       Impact factor: 5.742

6.  Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn's Disease.

Authors:  Simon Kusan; Güzin Surat; Matthias Kelm; Friedrich Anger; Mia Kim; Christoph-Thomas Germer; Nicolas Schlegel; Sven Flemming
Journal:  J Clin Med       Date:  2022-07-26       Impact factor: 4.964

Review 7.  Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α.

Authors:  Jihye Park; Jae Hee Cheon
Journal:  Korean J Intern Med       Date:  2022-07-27       Impact factor: 3.165

8.  Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn's disease.

Authors:  Arno R Bourgonje; Marta S Alexdottir; Antonius T Otten; Roberta Loveikyte; Anne-Christine Bay-Jensen; Martin Pehrsson; Hendrik M van Dullemen; Marijn C Visschedijk; Eleonora A M Festen; Rinse K Weersma; Morten A Karsdal; Klaas Nico Faber; Joachim H Mortensen; Gerard Dijkstra
Journal:  Aliment Pharmacol Ther       Date:  2022-06-06       Impact factor: 9.524

9.  MRI characteristics of proctitis in Crohn's disease on perianal MRI.

Authors:  Charlotte J Tutein Nolthenius; Shandra Bipat; Banafsche Mearadji; Anje M Spijkerboer; Cyriel Y Ponsioen; Alexander D Montauban van Swijndregt; Jaap Stoker
Journal:  Abdom Radiol (NY)       Date:  2016-10

Review 10.  Medical Therapy of Perianal Crohn's Disease.

Authors:  Thomas Klag; Martin Goetz; Eduard F Stange; Jan Wehkamp
Journal:  Viszeralmedizin       Date:  2015-07-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.